Skip to main content
. 2021 Sep 23;12:717688. doi: 10.3389/fimmu.2021.717688

Figure 2.

Figure 2

Correlation of PTP4A3 expression level with prognosis values in urothelial tract cancer in the GEPIA database. OS and DFS in patients with differential PTP4A3 expression in bladder urothelial carcinoma (BLCA) (A, B), chRCC (KICH) (C, D), ccRCC(KIRC) (E, F), pRCC (KIRP) (G, H), ovarian serous cystadenocarcinoma (OV) (I, J), prostate adenocarcinoma (PRAD) (K, L), uterine corpus endometrial carcinoma (UCEC) (M, N), uterine carcinosarcoma (UCS) (O, P). OS, overall survival; DFS, disease free survival.